Trial intelligence / Profile preview

Lidocaine Infusion in Functional Endoscopic Sinus Surgery

NCT03047070Phase 2Completed

Sponsor
Assiut University
Start
Feb 2017
Primary completion
Dec 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in intraoperative bleeding (2 arms), sponsored by Assiut University. Primary endpoint: Intraoperative bleeding. Started Feb 2017; status: completed.

02

Drugs

Lidocaine Hydrochloride Injection, without epinephrine
03

Conditions

intraoperative bleeding

Beyond the preview

Go deeper on NCT03047070.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03047070.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call